Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer

Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer

The mechanisms underlying the antineoplastic effects of oxicams have not been fully elucidated. We aimed to assess the effect of classic and novel oxicams on the expression/secretion of macrophage-associated chemokines (RTqPCR/Luminex xMAP) in colorectal adenocarcinoma cells, and on the expression o...

Full description

Bibliographic Details
Main Authors:	Paulina Lewandowska, Izabela Szczuka, Iwona Bednarz-Misa, Berenika M. Szczęśniak-Sięga, Katarzyna Neubauer, Magdalena Mierzchała-Pasierb, Marek Zawadzki, Wojciech Witkiewicz, Małgorzata Krzystek-Korpacka
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Molecules
Subjects:	non-steroidal anti-inflammatory drugs (NSAIDs) drug repurposing monocyte chemoattractant protein (MCP) macrophage inflammatory protein (MIP) immunotherapy piroxicam
Online Access:	https://www.mdpi.com/1420-3049/26/23/7375

Similar Items

Heat Shock Proteins HSPA1 and HSP90AA1 Are Upregulated in Colorectal Polyps and Can Be Targeted in Cancer Cells by Anti-Inflammatory Oxicams with Arylpiperazine Pharmacophore and Benzoyl Moiety Substitutions at Thiazine Ring
by: Izabela Szczuka, et al.
Published: (2021-10-01)

Interaction of Oxicam Derivatives with the Artificial Models of Biological Membranes—Calorimetric and Fluorescence Spectroscopic Study
by: Jadwiga Maniewska, et al.
Published: (2022-08-01)

Comparison of oral and sublingual piroxicam for management of postoperative pain after mandibular third molar surgery: A prospective, randomized study
by: Shruti Shashikant Phulgirkar, et al.
Published: (2016-01-01)

Selective in vitro cytotoxic effects of piroxicam and mefenamic acid on several cancer cells lines.
by: Somchit, M.N, et al.
Published: (2009)

Solubility Enhancement of Betamethasone, Meloxicam and Piroxicam by Use of Choline-Based Deep Eutectic Solvents
by: Salva Golgoun, et al.
Published: (2021-03-01)

Khaya senegalensis inhibits piroxicam mediated gastro-toxicity in wistar rats
by: Fatima Nnawodu Ishaq, et al.
Published: (2014-11-01)

Novel microwave-assisted solid dispersion technology enhances piroxicam dissolution and therapeutic efficacy: an in vitro and in vivo study
by: Charit Kumar, et al.
Published: (2025-02-01)

Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam
by: Meenakshi Bhatia, et al.
Published: (2020-08-01)

Formulation and evaluation of topical piroxicam microemulgel for arthritis
by: Mehreen Sattar, et al.
Published: (2023-06-01)

Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies
by: A. Notarnicola, et al.
Published: (2014-11-01)

Reducing ulcerogenic effect of self-nano emulsifying drug delivery system of piroxicam
by: Iis Wahyuningsih, et al.
Published: (2018-11-01)

The effect of piroxicam on the formation of postoperative, intraabdominal adhesion in rats
by: Maghsoudi Hemmat, et al.
Published: (2008-01-01)

Study on optimization of ternary complex of piroxicam-β-cyclodextrin-lysine inclusion in supercritical CO2
by: Phan Minh Vuong, et al.
Published: (2021-09-01)

Effects on muscle performance of NSAID treatment with Piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. a double blind randomized controlled trial
by: Beyer Ingo, et al.
Published: (2011-12-01)

A prospective study to compare the effects of preemptive piroxicam and oral dexamethasone on edema, trismus and pain in third molar surgery: A randomized controlled trial
by: Prashasti Sharma, et al.
Published: (2024-01-01)

COMPARATIVE EVALUATION OF KETOPROFEN CREAM WITH DICLOFENAC AND PIROXICAM CREAM IN PATIENTS WITH RHEUMATOID ARTHRITIS DISORDERS:
by: Muhammad Razi Ullah Khan, et al.
Published: (2015-01-01)

EVALUATION OF CHONDROPROTECTIVE EFFECTS OF INTRA ARTICULAR PIROXICAM IN POST-TRAUMATIC OSTEOARTHRITIS MODEL OF RAT
by: Noaman Ishaq, et al.
Published: (2021-04-01)

Salt-Induced Homogeneous Liquid–Liquid Microextraction of Piroxicam and Meloxicam from Human Urine Prior to Their Determination by HPLC-DAD
by: Natalia Manousi, et al.
Published: (2022-06-01)

Preparation and characterization of novel anti-inflammatory biological agents based on piroxicam-loaded poly-ε-caprolactone nano-particles for sustained NSAID delivery
by: Azizeh Rahmani Del Bakhshayesh, et al.
Published: (2020-01-01)

Comparison Efficacy of Topical Piroxicam Gel and Lidocaine with Intravenous Pethidine in Reducing Pain during ESWL
by: F Mohammad Alibeigi, et al.
Published: (2011-06-01)

Effect of piroxicam, metamizol, and S-adenosylmethionine in a murine model of experimental trichomoniasis
by: Nogal-Ruiz J.J., et al.
Published: (2005-03-01)

Synthesis and biological evaluation of Piroxicam derivative as a lead chelator
by: Hosseini Sayed Masoud, et al.
Published: (2019-06-01)

Comparison the effects of ginger (Zingiber officinale) jelly and piroxicam jelly on pain of knee osteoarthritis
by: Morteza Dehghan, et al.
Published: (2018-04-01)

Assessing the variability and the role of inflammatory cytokines and monocyte chemoattractant protein-1 (MCP-1) in predicting stroke among hypertensives: A case-control study
by: Samuel Asamoah Sakyi, et al.
Published: (2022-12-01)

Investigating the Effect of Basic Amino Acids and Glucosamine on the Solubility of Ibuprofen and Piroxicam
by: Hadi Valizadeh, et al.
Published: (2023-07-01)

Design, Synthesis, Antinociceptive and Anti-Inflammatory Activities of Novel Piroxicam Analogues
by: Eliezer J. Barreiro, et al.
Published: (2012-11-01)

Piroxicam voltammetric determination by ultra low cost pencil graphite electrode
by: Isaac Yves Lopes de Macêdo, et al.
Published: (2020-03-01)

Thiosemicarbazide derivative-functionalized carbon nanotube for simultaneous determination of isoprenaline and piroxicam
by: Mohammad Mazloum‐Ardakani, et al.
Published: (2017-04-01)

Formulation and evaluation of buccal films of piroxicam co-crystals
by: Anand Ammanage, et al.
Published: (2020-05-01)

SCREENING OF PIROXICAM SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) USING FRACTIONAL FACTORIAL DESIGN
by: Septiawan Adi Nugroho, et al.
Published: (2023-06-01)

Optimization of piroxicam tablet formula using flowlac, avicel and compritol by Simplex Lattice Design Method
by: Tuti Sri Suhesti, et al.
Published: (2009-09-01)

Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)

Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)

Serum and Erythrocyte Antioxidant Defense in Colorectal Cancer Patients during Early Postoperative Period: Potential Modifiers and Impact on Clinical Outcomes
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2021-06-01)

Quasi-Dynamic Dissolution of Electrospun Polymeric Nanofibers Loaded with Piroxicam
by: Urve Paaver, et al.
Published: (2019-09-01)

Acute generalized exanthematous pustulosis induced by piroxicam
by: Ingrid Bissinger, et al.
Published: (2016-10-01)

Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation
by: Prabhakar Panzade, et al.
Published: (2017-09-01)

Effect of Additives on the Solubility and Dissolution of Piroxicam From Prepared Hard Gelatin Capsule
by: Eman B. H. Al-Khedairy
Published: (2017-02-01)

Synthesis and assessment of piroxicam derivatives as potential chelating agents and antioxidants for lead poisoning treatment
by: Ali Salmani, et al.
Published: (2024-10-01)

Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers
by: Mohammad Barzegar-jalali, et al.
Published: (2014-09-01)